LIGAND PHARMACEUTICALS INC
LGND
DELAYED 1 MONTH
15 insider filings · Latest: Jun 5, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | Jun 2 10:22 PM | Andrew ReardonCLO & Secretary | Sale | 5,000 | $227.06 | $1.1M | 41,382(D) | View → |
| May 13, 2026 | May 15 1:08 AM | John W KozarichDirector | Sale | 1,575 | $223.50 | $352.0K | 41,786(D) | View → |
| May 12, 2026 | May 15 1:08 AM | John W KozarichDirector | Sale | 459 | $224.00 | $102.8K | 41,786(D) | View → |
| May 1, 2026 | May 15 1:08 AM | John W KozarichDirector | Sale | 467 | $231.80 | $108.3K | 41,786(D) | View → |
| May 1, 2026 | May 5 12:20 AM | Andrew ReardonCLO & Secretary | Sale | 5,000 | $231.31 | $1.2M | 41,382(D) | View → |
| Mar 11, 2026 | Mar 13 11:29 PM | Octavio EspinozaChief Financial Officer | Sale | 3,057 | $225.00 | $687.8K | 21,010(D) | View → |
| Mar 4, 2026 | Mar 6 11:51 PM | Andrew ReardonCLO & Secretary | Sale | 5,000 | $206.35 | $1.0M | 36,869(D) | View → |
| Mar 4, 2026 | Mar 6 11:49 PM | Octavio EspinozaChief Financial Officer | Sale | 13,423 | $205.83 | $2.8M | 21,662(D) | View → |
| Mar 3, 2026 | Mar 5 4:05 PM | Stephen L SabbaDirector | Sale | 2,034 | $201.50 | $409.9K | 33,793(D) | View → |
| Mar 2, 2026 | Mar 5 2:04 AM | John W KozarichDirector | Sale | 467 | $200.50 | $93.6K | 42,720(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 5, 2026 | Jun 9 11:42 PM | Martine ZimmermannDirector | Grant/Award | 2,938 | $237.00 | 2,938(D) | View → |
| Jun 5, 2026 | Jun 9 11:41 PM | Stephen L SabbaDirector | Grant/Award | 2,938 | $237.00 | 2,938(D) | View → |
| Jun 5, 2026 | Jun 9 11:41 PM | John L LamattinaDirector | Grant/Award | 2,938 | $237.00 | 2,938(D) | View → |
| Jun 5, 2026 | Jun 9 11:40 PM | John W KozarichDirector | Grant/Award | 2,938 | $237.00 | 2,938(D) | View → |
| Jun 5, 2026 | Jun 9 11:35 PM | Jason HaasDirector | Grant/Award | 2,938 | $237.00 | 2,938(D) | View → |
| Jun 5, 2026 | Jun 9 11:35 PM | Nancy Ryan GrayDirector | Grant/Award | 2,938 | $237.00 | 2,938(D) | View → |
| Jun 1, 2026 | Jun 2 10:22 PM | Andrew ReardonCLO & Secretary | Option Exercise | 5,000 | $52.27 | 39,444(D) | View → |
| May 27, 2026 | May 28 11:43 PM | Octavio EspinozaChief Financial Officer | Option Exercise | 1,736 | $63.62 | 17,407(D) | View → |
| May 13, 2026 | May 15 1:08 AM | John W KozarichDirector | Option Exercise | 1,575 | $69.51 | 0(D) | View → |
| May 12, 2026 | May 15 1:08 AM | John W KozarichDirector | Option Exercise | 459 | $69.51 | 1,575(D) | View → |
| May 1, 2026 | May 5 12:20 AM | Andrew ReardonCLO & Secretary | Option Exercise | 5,000 | $52.27 | 44,444(D) | View → |
| Mar 11, 2026 | Mar 13 11:29 PM | Octavio EspinozaChief Financial Officer | Option Exercise | 2,405 | $92.65 | 0(D) | View → |
| Mar 4, 2026 | Mar 6 11:51 PM | Andrew ReardonCLO & Secretary | Option Exercise | 5,000 | $52.27 | 54,444(D) | View → |
| Mar 4, 2026 | Mar 6 11:49 PM | Octavio EspinozaChief Financial Officer | Option Exercise | 2,073 | $80.72 | 0(D) | View → |
| Mar 3, 2026 | Mar 5 4:05 PM | Stephen L SabbaDirector | Option Exercise | 2,034 | $69.51 | 0(D) | View → |